Dr. Krishna Mallela is currently a Professor in the Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, United States. His current research interests include SARS-CoV-2 variants, antibody therapeutics, and protein subunit vaccines.